Er Therapeutics Stock Price on March 22, 2023
| PNGM Stock | USD 0.0001 0.00 0.000003% |
Below is the normalized historical share price chart for Er Therapeutics extending back to December 07, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Er Therapeutics stands at 0.0001, as last reported on the 26th of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
If you're considering investing in PNGM Stock, it is important to understand the factors that can impact its price. We have found four technical indicators for Er Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Er Therapeutics' rate of daily change of 1.0, and Day Median Price of 1.0E-4 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
As of the 26th of December 2024, Sale Purchase Of Stock is likely to grow to about 34.5 K, though Total Stockholder Equity is likely to grow to (96.1 K). . PNGM Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta 10.396 |
PNGM |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PNGM |
Based on monthly moving average Er Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Er Therapeutics by adding Er Therapeutics to a well-diversified portfolio.
Price Book 143.7 K | Book Value (0) | Enterprise Value 122.4 K | Enterprise Value Ebitda (0.25) | Shares Outstanding 58.3 M |
Er Therapeutics Valuation on March 22, 2023
It is possible to determine the worth of Er Therapeutics on a given historical date. On March 22, 2023 PNGM was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Er Therapeutics stock. Still, in general, we apply an absolute valuation method to find Er Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Er Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Er Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
03/22/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest Er Therapeutics | | | Er Therapeutics History | | | Er Therapeutics Valuation | Previous | Next |
Er Therapeutics Trading Date Momentum on March 22, 2023
| On March 23 2023 Er Therapeutics was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on March 23, 2023 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Er Therapeutics Fundamentals Correlations and Trends
By evaluating Er Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Er Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PNGM financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Er Therapeutics Stock history
Er Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PNGM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Er Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Er Therapeutics stock prices may prove useful in developing a viable investing in Er Therapeutics
| Last Reported | Projected for Next Year | ||
| Net Loss | -384.3 K | -403.5 K |
Er Therapeutics Stock Technical Analysis
Er Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Er Therapeutics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Er Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Er Therapeutics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Er Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Er Therapeutics shares will generate the highest return on investment. By undertsting and applying Er Therapeutics stock market strength indicators, traders can identify Er Therapeutics entry and exit signals to maximize returns
When determining whether Er Therapeutics is a strong investment it is important to analyze Er Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Er Therapeutics' future performance. For an informed investment choice regarding PNGM Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Er Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Er Therapeutics. If investors know PNGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Er Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.95) |
The market value of Er Therapeutics is measured differently than its book value, which is the value of PNGM that is recorded on the company's balance sheet. Investors also form their own opinion of Er Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Er Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Er Therapeutics' market value can be influenced by many factors that don't directly affect Er Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Er Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Er Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Er Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.